NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1487668463
Verify on CMS → Sheila Gupta
Endocrinology, Diabetes & Metabolism Physician in Ormond Beach, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 462 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
43%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Sheila Gupta carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 4,601 Medicare Part D claims in 2023.
- 75/100
- CMS neutral score · not measured
- 5K
- Part D claims, 2023
- 43%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1487668463 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1487668463
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-NEUTRAL 75/100
- RX-MID 4,601
- BOOK-LIGHT 519 in Florida
- PHOTO-ENUM Jose Ortiz · 2006
Sheila Gupta's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
4,601 ≥ 93rd percentile 93% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Sheila Gupta practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sheila Gupta?
CMS neutral score, not measuredPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
4,601 74% vs specialty avg
MIPS final score
75/100
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1487668463 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Gender | Female |
| NPI Issued | 07/28/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Hospital and facility affiliations
Facilities where Sheila Gupta bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Amol K Gupta MD Corporation
Ormond Beach, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Sheila Gupta. To verify Sheila Gupta's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Sheila Gupta - brand share 51.0%
Endocrinology, Diabetes & Metabolism Physician average
51% brand-name claims vs 43% generic, on 4,601 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,601
Total Claims
$2.1M
Total Drug Cost
462
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 10,844
- Total Day Supply
- 321,604
- Brand vs Generic
- 51% brand / 43% generic
- Brand Drug Cost
- $1.9M
- Generic Drug Cost
- $51K
- Antibiotic Claims
- 14
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.69
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 36, 65-74: 215, 75-84: 169, 85+: 42
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Sheila Gupta prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
420 claims
- Ozempic
Ozempic
285 claims
- Synthroid
Synthroid
280 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
210 claims
- Metformin Hcl
Metformin Hcl
186 claims
- Metformin Hcl Er 162
Metformin Hcl Er
162 claims
- Atorvastatin Calcium 117
Atorvastatin Calcium
117 claims
- Tresiba Flextouch … 103
Tresiba Flextouch U-200
103 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 420 |
| Ozempic Semaglutide | 285 |
| Synthroid Levothyroxine Sodium | 280 |
| Rosuvastatin Calcium | 210 |
| Metformin Hcl | 186 |
| Metformin Hcl Er Metformin Hcl | 162 |
| Atorvastatin Calcium | 117 |
| Tresiba Flextouch U-200 Insulin Degludec | 103 |
| Farxiga Dapagliflozin Propanediol | 102 |
| Novolog Flexpen Insulin Aspart | 99 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Sheila Gupta fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Sheila Gupta's 4,601 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gupta, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Gupta.
One of 519 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Dr. Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Sheila Gupta's specialty? ▼
Sheila Gupta specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Ormond Beach, Florida.
How much does Sheila Gupta prescribe under Medicare Part D? ▼
In 2023, Sheila Gupta wrote 4,601 Medicare Part D claims totaling $2.1M in drug costs for 462 beneficiaries.
What is Sheila Gupta's Medicare quality score? ▼
Sheila Gupta has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Sheila Gupta located? ▼
Sheila Gupta is located at 345 CLYDE MORRIS BLVD, Ormond Beach, FL, 32174. Phone: (386) 673-0075.
What is Sheila Gupta's NPI number? ▼
Sheila Gupta's National Provider Identifier (NPI) is 1487668463, issued on 07/28/2006.
Does Sheila Gupta prescribe more brand-name or generic drugs? ▼
Sheila Gupta's prescribing is 51% brand-name and 43% generic drugs by claim count, with $1.9M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Sheila Gupta prescribe most often? ▼
Based on 2023 Medicare Part D data, Sheila Gupta's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Synthroid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sheila Gupta accept Medicare? ▼
Sheila Gupta appears in CMS Medicare data with 4,601 Part D claims and 462 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sheila Gupta's credentials? ▼
Sheila Gupta's NPI is 1487668463. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.